Clinical Trials & COVID-19

HER2 targeted therapy for solid tumors

Learn about an investigational cancer therapy designed for people with HER2-overexpressing solid tumors in the CT-0508 Study 101 clinical trial.

If you have a HER2-positive tumor and are no longer responding to current cancer treatment, you may qualify to join this clinical trial. Find out what to expect during the study or contact a study clinic near you today.